Regenerative Cell Therapy

InGeneron Extends Series D Financing to $43 Million to Bring Regenerative Cell Therapy into the Clinic

June 11, 2019  HOUSTON–(BUSINESS WIRE)–InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced today the extension of…